![](/sites/default/files/styles/img_search_list_desktop/public/respiratory-liste.jpg?h=0c8b8d2d&itok=tkknV3dX)
SCOR Global Life recently held two events on respiratory diseases to share our insights and technical expertise with our clients.
SCOR Global Life recently held two events on respiratory diseases to share our insights and technical expertise with our clients.
SCOR a émis avec succès des titres obligataires « Regulation S » super subordonnés à durée indéterminée pour un montant de USD 625 millions
SCOR participated in a trial organized by the Chief Risk Officer Forum to design a common taxonomy that could be used to capture digital events.
AI is a game changer for the insurance industry. The new risks it carries for clients must be assessed, while the opportunities for internal efficiencies should be embraced.
SCOR helps insurers to more effectively handle, classify, interpret and extract essential information by leveraging raw text technology, leading to improved decisions in key areas.
SCOR informe que son Document de référence 2017 a été déposé auprès de l’Autorité des marchés financiers (AMF) le 23 février 2018.
SCOR informe que son Document de référence 2017 a été déposé auprès de l’Autorité des marchés financiers (AMF) le 23 février 2018.
On February 12, the 5th SCOR Young European Researcher Prize for Research into Alzheimer’s disease was presented to Erik Portelius of Sweden’s Gothenburg University, for his findings on a new biomarker that enables ea
On February 12, the 5th SCOR Young European Researcher Prize for Research into Alzheimer’s disease was presented to Erik Portelius of Sweden’s Goteborg University, for his findings on a new biomarker that enables earl